| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 5,190,837 | 126,657,000 | 46.71% | ||
| 2 | LA JOLLA PHARMACEUTICAL CO | 2,914,970 | 81,007,000 | 29.87% | ||
| 3 | OPKO HEALTH INC | 2,475,000 | 20,815,000 | 7.68% | ||
| 4 | BIOMARIN | 182,300 | 19,200,000 | 7.08% | ||
| 5 | Opko Health, Inc. | 14,000,000 | 18,247,000 | 6.73% | PRN | |
| 6 | MERRIMACK PHARMACEUTI | 3,500,000 | 5,259,000 | 1.94% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-15-007805, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
